408 related articles for article (PubMed ID: 29045918)
41. Cytotoxicity of octal-bromide zinc phthalocyanine after photodynamic therapy with different light sources.
Machado AH; Soares CP; Beltrame Junior M; Pacheco MT; Da Silva NS
Photomed Laser Surg; 2008 Oct; 26(5):455-9. PubMed ID: 18922089
[TBL] [Abstract][Full Text] [Related]
42. Two combined photosensitizers: a goal for more effective photodynamic therapy of cancer.
Acedo P; Stockert JC; Cañete M; Villanueva A
Cell Death Dis; 2014 Mar; 5(3):e1122. PubMed ID: 24625981
[TBL] [Abstract][Full Text] [Related]
43. Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4.
Xue LY; Chiu SM; Oleinick NL
Oncogene; 2001 Jun; 20(26):3420-7. PubMed ID: 11423992
[TBL] [Abstract][Full Text] [Related]
44. Development of therapeutic Au-methylene blue nanoparticles for targeted photodynamic therapy of cervical cancer cells.
Yu J; Hsu CH; Huang CC; Chang PY
ACS Appl Mater Interfaces; 2015 Jan; 7(1):432-41. PubMed ID: 25494339
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of theranostic nanocarriers for near-infrared imaging and photodynamic therapy on human prostate cancer cells.
Leandro FZ; Martins J; Fontes AM; Tedesco AC
Colloids Surf B Biointerfaces; 2017 Jun; 154():341-349. PubMed ID: 28365423
[TBL] [Abstract][Full Text] [Related]
46. Molecular-target-based anticancer photosensitizer: synthesis and in vitro photodynamic activity of erlotinib-zinc(II) phthalocyanine conjugates.
Zhang FL; Huang Q; Liu JY; Huang MD; Xue JP
ChemMedChem; 2015 Feb; 10(2):312-20. PubMed ID: 25336150
[TBL] [Abstract][Full Text] [Related]
47. Peptide-substituted phthalocyanine photosensitizers: design, synthesis, photophysicochemical and photobiological studies.
Göksel M; Durmuş M; Atilla D
Photochem Photobiol Sci; 2016 Oct; 15(10):1318-1329. PubMed ID: 27714248
[TBL] [Abstract][Full Text] [Related]
48. A Protein-Polymer Bioconjugate-Coated Upconversion Nanosystem for Simultaneous Tumor Cell Imaging, Photodynamic Therapy, and Chemotherapy.
Dong C; Liu Z; Wang S; Zheng B; Guo W; Yang W; Gong X; Wu X; Wang H; Chang J
ACS Appl Mater Interfaces; 2016 Dec; 8(48):32688-32698. PubMed ID: 27934134
[TBL] [Abstract][Full Text] [Related]
49. [Effect of zinc phthalocyanine-mediated photodynamic therapy on bone marrow purging, an experimental study].
Huang HF; Chen YZ; Wu Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):986-91. PubMed ID: 12899802
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of phthalocyanine conjugates with gold nanoparticles and liposomes for photodynamic therapy.
Nombona N; Maduray K; Antunes E; Karsten A; Nyokong T
J Photochem Photobiol B; 2012 Feb; 107():35-44. PubMed ID: 22209036
[TBL] [Abstract][Full Text] [Related]
51. Phthalocyanine derivatives possessing 2-(morpholin-4-yl)ethoxy groups as potential agents for photodynamic therapy.
Kucinska M; Skupin-Mrugalska P; Szczolko W; Sobotta L; Sciepura M; Tykarska E; Wierzchowski M; Teubert A; Fedoruk-Wyszomirska A; Wyszko E; Gdaniec M; Kaczmarek M; Goslinski T; Mielcarek J; Murias M
J Med Chem; 2015 Mar; 58(5):2240-55. PubMed ID: 25700089
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of one- and two-photon activated photodynamic therapy with pyropheophorbide-a methyl ester in human cervical, lung and ovarian cancer cells.
Luo T; Wilson BC; Lu QB
J Photochem Photobiol B; 2014 Mar; 132():102-10. PubMed ID: 24607610
[TBL] [Abstract][Full Text] [Related]
53. The in vitro photodynamic effect of laser activated gallium, indium and iron phthalocyanine chlorides on human lung adenocarcinoma cells.
Maduray K; Odhav B
J Photochem Photobiol B; 2013 Nov; 128():58-63. PubMed ID: 24007866
[TBL] [Abstract][Full Text] [Related]
54. Study of the stabilization of zinc phthalocyanine in sol-gel TiO2 for photodynamic therapy applications.
Lopez T; Ortiz E; Alvarez M; Navarrete J; Odriozola JA; Martinez-Ortega F; Páez-Mozo EA; Escobar P; Espinoza KA; Rivero IA
Nanomedicine; 2010 Dec; 6(6):777-85. PubMed ID: 20493967
[TBL] [Abstract][Full Text] [Related]
55. Induction of apoptotic cell death by photodynamic therapy in human keratinocytes.
Ketabchi A; MacRobert A; Speight PM; Bennett JH
Arch Oral Biol; 1998 Feb; 43(2):143-9. PubMed ID: 9602293
[TBL] [Abstract][Full Text] [Related]
56. High oxygen partial pressure increases photodynamic effect on HeLa cell lines in the presence of chloraluminium phthalocyanine.
Bajgar R; Kolarova H; Bolek L; Binder S; Pizova K; Hanakova A
Anticancer Res; 2014 Aug; 34(8):4095-9. PubMed ID: 25075034
[TBL] [Abstract][Full Text] [Related]
57. Photodynamic performance of zinc phthalocyanine in HeLa cells: A comparison between DPCC liposomes and BSA as delivery systems.
M Garcia A; de Alwis Weerasekera H; Pitre SP; McNeill B; Lissi E; Edwards AM; Alarcon EI
J Photochem Photobiol B; 2016 Oct; 163():385-90. PubMed ID: 27614847
[TBL] [Abstract][Full Text] [Related]
58. In vitro photodynamic inactivation of Cryptococcus neoformans melanized cells with chloroaluminum phthalocyanine nanoemulsion.
Rodrigues GB; Primo FL; Tedesco AC; Braga GU
Photochem Photobiol; 2012; 88(2):440-7. PubMed ID: 22145636
[TBL] [Abstract][Full Text] [Related]
59. Mitochondria, endoplasmic reticulum and actin filament behavior after PDT with chloroaluminum phthalocyanine liposomal in HeLa cells.
Maftoum-Costa M; Naves KT; Oliveira AL; Tedesco AC; da Silva NS; Pacheco-Soares C
Cell Biol Int; 2008 Aug; 32(8):1024-8. PubMed ID: 18485750
[TBL] [Abstract][Full Text] [Related]
60. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.
Miller JD; Baron ED; Scull H; Hsia A; Berlin JC; McCormick T; Colussi V; Kenney ME; Cooper KD; Oleinick NL
Toxicol Appl Pharmacol; 2007 Nov; 224(3):290-9. PubMed ID: 17397888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]